NCT05193552View on ClinicalTrials.gov

Usage of Spirometry in Managing IgG Therapy in CVID with Airway Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Common Variable Immunodeficiency
Interventions
DRUG

Hizentra

subjects level of immunoglobulin replacement therapy will be adjusted for bioavailability as per manufacturer's instructions

Trial Locations (1)

35205

RECRUITING

Community Health 20, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER